ERBA Diagnostics, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2013. Net revenues increased by 83% to $6,941,000 in the three months ended September 30, 2013 from $3,789,000 in the three months ended September 30, 2012. Income from operations totaled $78,000 in the three months ended September 30, 2013 as compared to an operating loss of $42,000 in the three months ended September 30, 2012. The company generated a consolidated net income of $129,000 in the three months ended September 30, 2013 (including the net income of $471,000 for Drew Scientific) as compared to a net loss of $97,000 in the three months ended September 30, 2012. Basic and diluted net income per common share was $0.00 in the three months ended September 30, 2013 as compared to basic and diluted net loss per common share of $0.01 in the three months ended September 30, 2012. Income before income taxes was $156,523 against loss before income taxes of $77,108 a year ago.

Net revenues increased by $8,165,000 to $20,538,000 in the nine months ended September 30, 2013 from $12,373,000 in the nine months ended September 30, 2012. Income from operations totaled $230,000 in the nine months ended September 30, 2013 as compared to an operating loss of $298,000 in the nine months ended September 30, 2012. The company generated a consolidated net loss of approximately $30,000 in the nine months ended September 30, 2013 (including the net income of $1,172,000 for Drew Scientific) as compared to a net loss of $534,000 in the nine months ended September 30, 2012. Basic and diluted net loss per common share was $0.00 in the nine months ended September 30, 2013 as compared to $0.02 in the nine months ended September 30, 2012. Income before income taxes was $49,498 against loss before income taxes of $459,139 a year ago.